List of works - Paweł Szymański

2,3-Dihydro-1H-cyclopenta[b]quinoline Derivatives as Acetylcholinesterase Inhibitors—Synthesis, Radiolabeling and Biodistribution ⬇️

scientific article published on August 13, 2012

Adaptation of high-throughput screening in drug discovery-toxicological screening tests.

scientific article published on 29 December 2011

Biological assessment of new tetrahydroacridine derivatives with fluorobenzoic moiety in vitro on A549 and HT-29 cell lines and in vivo on animal model

scientific article published on 24 May 2020

Development of copper based drugs, radiopharmaceuticals and medical materials.

scientific article

Discovery of New Cyclopentaquinoline Analogues as Multifunctional Agents for the Treatment of Alzheimer's Disease

scientific article published on 24 January 2019

Evaluation of poly(amidoamine) dendrimers as potential carriers of iminodiacetic derivatives using solubility studies and 2D-NOESY NMR spectroscopy.

scientific article

Metabolite Profiling of Eastern Teaberry (Gaultheria procumbens L.) Lipophilic Leaf Extracts with Hyaluronidase and Lipoxygenase Inhibitory Activity.

scientific article published on 6 March 2017

New Biopolymer Nanoparticles Improve the Solubility of Lipophilic Megestrol Acetate.

scientific article published on 6 February 2016

New Tetrahydroacridine Hybrids with Dichlorobenzoic Acid Moiety Demonstrating Multifunctional Potential for the Treatment of Alzheimer's Disease

scientific article published on 26 May 2020

New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer's disease

scientific article published in December 2017

New tacrine analogs as acetylcholinesterase inhibitors - theoretical study with chemometric analysis.

scientific article published on 4 March 2013

New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease

scientific article published on 05 June 2018

Novel tetrahydroacridine and cyclopentaquinoline derivatives with fluorobenzoic acid moiety induce cell cycle arrest and apoptosis in lung cancer cells by activation of DNA damage signaling.

scientific article

Novel tetrahydroacridine derivatives with iodobenzoic acid moiety as multifunctional acetylcholinesterase inhibitors.

scientific article

Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells

scientific article published on 16 July 2019

Radiolabeled Peptides and Antibodies in Medicine

scientific article published on 16 December 2020

Re-evaluation of the retention time prediction "polarity" model in the context of the development of a stationary phase variable.

scientific article published in July 2014

Synthesis and biological activity of derivatives of tetrahydroacridine as acetylcholinesterase inhibitors ⬇️

scientific article published on May 12, 2011

Synthesis and biological activity of new donepezil-hydrazinonicotinamide hybrids.

scientific article published on 14 February 2013

Synthesis and biological evaluation of 1,3,4-thiadiazole analogues as novel AChE and BuChE inhibitors.

scientific article published on 11 January 2013

Synthesis, biological activity and HPLC validation of 1,2,3,4-tetrahydroacridine derivatives as acetylcholinesterase inhibitors.

scientific article published on 22 April 2011

Synthesis, biological activity and molecular modeling of 4-fluoro-N-[ω-(1,2,3,4-tetrahydroacridin-9-ylamino)-alkyl]-benzamide derivatives as cholinesterase inhibitors

scientific article published on 15 November 2012

Synthesis, biological evaluation and molecular modeling of new tetrahydroacridine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.

scientific article

Synthesis, physicochemical and biological studies of technetium-99m labeled tacrine derivative as a diagnostic tool for evaluation of cholinesterase level

scientific article published on 7 December 2016

Taxodione and Extracts from Salvia austriaca Roots as Human Cholinesterase Inhibitors.

scientific article published on December 2015

Tetrahydroacridine derivatives with dichloronicotinic acid moiety as attractive, multipotent agents for Alzheimer's disease treatment

scientific article published on 9 January 2018

Tetrahydroacridine derivatives with fluorobenzoic acid moiety as multifunctional agents for Alzheimer's disease treatment

scientific article published on 5 May 2017

List of works by Paweł Szymański

2,3-Dihydro-1H-cyclopenta[b]quinoline Derivatives as Acetylcholinesterase Inhibitors—Synthesis, Radiolabeling and Biodistribution ⬇️

Adaptation of high-throughput screening in drug discovery-toxicological screening tests.

Biological assessment of new tetrahydroacridine derivatives with fluorobenzoic moiety in vitro on A549 and HT-29 cell lines and in vivo on animal model

Development of copper based drugs, radiopharmaceuticals and medical materials.

Discovery of New Cyclopentaquinoline Analogues as Multifunctional Agents for the Treatment of Alzheimer's Disease

Evaluation of poly(amidoamine) dendrimers as potential carriers of iminodiacetic derivatives using solubility studies and 2D-NOESY NMR spectroscopy.

Metabolite Profiling of Eastern Teaberry (Gaultheria procumbens L.) Lipophilic Leaf Extracts with Hyaluronidase and Lipoxygenase Inhibitory Activity.

New Biopolymer Nanoparticles Improve the Solubility of Lipophilic Megestrol Acetate.

New Tetrahydroacridine Hybrids with Dichlorobenzoic Acid Moiety Demonstrating Multifunctional Potential for the Treatment of Alzheimer's Disease

New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer's disease

New tacrine analogs as acetylcholinesterase inhibitors - theoretical study with chemometric analysis.

New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease

Novel tetrahydroacridine and cyclopentaquinoline derivatives with fluorobenzoic acid moiety induce cell cycle arrest and apoptosis in lung cancer cells by activation of DNA damage signaling.

Novel tetrahydroacridine derivatives with iodobenzoic acid moiety as multifunctional acetylcholinesterase inhibitors.

Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells

Radiolabeled Peptides and Antibodies in Medicine

Re-evaluation of the retention time prediction "polarity" model in the context of the development of a stationary phase variable.

Synthesis and biological activity of derivatives of tetrahydroacridine as acetylcholinesterase inhibitors ⬇️

Synthesis and biological activity of new donepezil-hydrazinonicotinamide hybrids.

Synthesis and biological evaluation of 1,3,4-thiadiazole analogues as novel AChE and BuChE inhibitors.

Synthesis, biological activity and HPLC validation of 1,2,3,4-tetrahydroacridine derivatives as acetylcholinesterase inhibitors.

Synthesis, biological activity and molecular modeling of 4-fluoro-N-[ω-(1,2,3,4-tetrahydroacridin-9-ylamino)-alkyl]-benzamide derivatives as cholinesterase inhibitors

Synthesis, biological evaluation and molecular modeling of new tetrahydroacridine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.

Synthesis, physicochemical and biological studies of technetium-99m labeled tacrine derivative as a diagnostic tool for evaluation of cholinesterase level

Taxodione and Extracts from Salvia austriaca Roots as Human Cholinesterase Inhibitors.

Tetrahydroacridine derivatives with dichloronicotinic acid moiety as attractive, multipotent agents for Alzheimer's disease treatment

Tetrahydroacridine derivatives with fluorobenzoic acid moiety as multifunctional agents for Alzheimer's disease treatment